New medication, staging criteria signal a potential shift in Alzheimer’s care
07/24/24 at 03:00 AM
New medication, staging criteria signal a potential shift in Alzheimer’s care
Psychiatric News; by Linda M. Richmond; 7/12/24
The latest antibody treatment for Alzheimer's disease may prompt the industry toward the use of biomarkers--rather than traditional cognitive and functional testing--for diagnosis and staging. Will the new drug make a meaningful difference in patients' lives despite its risks and hefty price tag?